Stay updated with breaking news from Bax Bcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CBL-514 is the first product to treat cellulite at the raised areas. Currently, there is no effective and safe cellulite treatment on the market. The global...
CBL-514 is the first product to treat cellulite at the raised areas.Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034.CBL-0201EFP...
NEW TAIPEI CITY, April 26, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) today announced the topline results of the CBL-0201EFP Phase 2 study,
/PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the...
Caliway Received First Approval of CBL-514 Pivotal Phase 3 Study Application for Subcutaneous Fat Reduction | 2024-01-23 21:12:00